Nova Southeastern University Researchers Receive $4 Million From CDC for ‘COVID Long Haulers’ Study

Many COVID-19 Patients Suffering Long-Lasting Effects After Recovery – NSU Only Institution to Receive This Grant to Begin New Study
Nova Southeastern University
28-Oct-2020 11:30 AM EDT, by Nova Southeastern University

Newswise — FORT LAUDERDALE/DAVIE, Fla. – As the COVID-19 pandemic continues to evolve, health care providers are finding more and more patients are experiencing lingering symptoms after recovering from the virus. These symptoms can vary from being bone-tired, utterly exhausted, or drained of energy , but in most cases they continue to negatively impact the patient’s overall well-being and ability to return to normal activities. While the medical community is still working hard to address the virus itself and racing toward a vaccine, there is very little known or being done to address these residual health issues being experienced by those now called “COVID long haulers.”

But all of that is about to change, thanks to research scientists at Nova Southeastern University (NSU.) 

“With our long-standing research into ME/Chronic Fatigue Syndrome, we’ve been selected by the Centers for Disease Control and Prevention to begin researching these symptoms in COVID-19 patients,” said Nancy Klimas, M.D. “Because the symptoms are so similar – joint and muscle pain, severe fatigue and memory and cognitive issues – to Chronic Fatigue Syndrome, NSU is uniquely positioned to study this emerging development in the pandemic.”

With more than 30 years of professional experience, Dr. Klimas has achieved international recognition for her research and clinical efforts in multi-symptom disorders, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Gulf War illness (GWI), fibromyalgia and other neuro-immune disorders. Because of her expertise and the work she is involved with at the university, the CDC has awarded NSU a federal contract of more than $4 million to study these residual symptoms in COVID-19 patients.

NSU is the only institution to receive this federal contract. 

Dr. Klimas, who is also the Director of NSU’s Institute for Neuro-Immune Medicine, said that similar symptoms were identified in patients after other viral infections, such as the severe acute respiratory syndrome (SARS) outbreak in 2003. Over the years, patients suffering from these symptoms were given a variety of treatments, including respiratory, cardiovascular and physical therapy. Unfortunately, it’s not a one-size-fits-all situation, and in some cases, existing therapies can actually make the patient worse.

That’s why this research is so important – with COVID-19 so widespread, there are going to be thousands upon thousands of long-haulers who are going to need help.

For this research study, NSU will work with the Florida Department of Health to identify potential participants. NSU researchers then will contact individuals to describe the study and to ask their interest and permission to be participate in the study. As you can imagine, this list is quite extensive – more than 40,000 patients and counting. In addition, NSU is working with partner health care providers, such as Community Health of South Florida, Inc. in Miami, to identify other patients. So between both pools of participants, NSU researchers want to have 2,200 individuals agree and opt in for the study.

“One of the things we want to ensure is that our group of participants is truly a diverse sample of people who are affected by this new syndrome,” said Nicole Cook, Ph.D., MPA, an associate professor of public health at NSU. “We hope to engage members of underserved communities, including minorities, who have been disproportionately impacted by COVID-19 and therefore will likely have a higher  number of ‘long haulers’.”

Cook said that the group will participate in various on-going online surveys to collect data, with a smaller sub-group (approximately 200) participating in clinic-based assessments. Regardless of which aspect of the study they are involved with, this research will not impact or impede any ongoing health care they may be receiving to treat their symptoms.

Along with Drs. Klimas and Cook, others on the NSU research team include Drs. Irma Rey and Alison Bested and nurse practitioners Drs. Violeta Renesca and Irina Rozenfeld.

“We need to understand and describe this new disease and we’re still in the early stages of learning about it,” said Klimas. “This study will provide the chance to see patients early on in their conditions, and that’s vital for development treatments.”


Be sure to sign up for NSU’s RSS feed so you don’t miss any of our news releases, guest editorials and other announcements. Please sign up HERE. You can also follow us on Twitter @NSUNews.




About Nova Southeastern University (NSU): At NSU, students don’t just get an education, they get the competitive edge they need for real careers, real contributions and real life. A dynamic, private research university, NSU is providing high-quality educational and research programs at the undergraduate, graduate, and professional degree levels. Established in 1964, the university includes 15 colleges, the 215,000-square-foot Center for Collaborative Research, the private JK-12 grade University School, the world-class NSU Art Museum Fort Lauderdale, and the Alvin Sherman Library, Research and Information Technology Center, one of Florida’s largest public libraries. NSU students learn at our campuses in Fort Lauderdale, Fort Myers, Jacksonville, Miami, Miramar, Orlando, Palm Beach, and Tampa, Florida, as well as San Juan, Puerto Rico, and online globally. With nearly 200,000 alumni across the nation and globe, the reach of the NSU community is worldwide.  Classified as having “high research activity” by the Carnegie Foundation for the Advancement of Teaching, NSU is one of only 50 universities nationwide to also be awarded Carnegie’s Community Engagement Classification, and is also the largest private institution in the United States that meets the U.S. Department of Education’s criteria as a Hispanic-serving Institution. Please visit for more information.

Filters close

Showing results

110 of 5419
Released: 15-Apr-2021 4:10 PM EDT
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
Perelman School of Medicine at the University of Pennsylvania

New findings from Penn suggest that people who have recovered from COVID-19 may only need a single mRNA vaccine dose. However, those who did not have COVID-19 did not have a full immune response until after a second vaccine dose, reinforcing the importance of completing the two recommended doses.

Released: 15-Apr-2021 4:00 PM EDT
June 2021 Issue of AJPH Comprises the Effects of COVID-19 on Drug Overdoses, E-cigarette Use, and Public Health Measures and Strategies
American Public Health Association (APHA)

June 2021 AJPH Issue highlights COVID-19 concerns in relation to fatal drug overdoses, drops in youth e-cigarette use, importance of public health measures, and strategies to protect correctional staff.

Newswise: 262150_web.jpg
Released: 15-Apr-2021 3:20 PM EDT
COVID-19 reduces access to opioid dependency treatment for new patients
Princeton University

COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.

Newswise: UGA to Establish National NIH-funded Center to Fight Flu
Released: 15-Apr-2021 2:45 PM EDT
UGA to Establish National NIH-funded Center to Fight Flu
University of Georgia

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research (CIDER). The contract will provide $1 million in first-year funding and is expected to be supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, for seven years and up to approximately $92 million.

Released: 15-Apr-2021 2:15 PM EDT
Meatpacking plants increased COVID-19 cases in US counties
University of California, Davis

An estimated 334,000 COVID-19 cases are attributable to meatpacking plants, resulting in $11.2 billion in economic damage, according to a new study led by a researcher at the University of California, Davis.

Newswise: 262052_web.jpg
Released: 15-Apr-2021 1:55 PM EDT
How to build a city that prioritizes public health
Colorado State University

Most people by now have memorized the public health guidelines meant to help minimize transmission of COVID-19: wash your hands, wear a mask, keep six feet apart from others. That part is easy.

Released: 15-Apr-2021 1:45 PM EDT
Wake Forest School of Medicine Begins Study to Test New Mask for Healthcare Workers
Wake Forest Baptist Health

Open Standard Industries, Inc. (OSI), manufacturer of the OSR-M1 non-valved reusable elastomeric face mask, is pleased to formally announce the launch of its first Institutional Review Board (IRB)-approved user feasibility study. The trial is being led by the departments of Biomedical Engineering and Infectious Diseases at Wake Forest School of Medicine, part of Wake Forest Baptist Health. Recruitment in the study is underway, and enrollment is expected to be completed by May 28, 2021.

Newswise: Major clinical trial to test Pfizer-BioNTech COVID-19 vaccine opens for enrollment at UTHealth in Houston
Released: 15-Apr-2021 1:45 PM EDT
Major clinical trial to test Pfizer-BioNTech COVID-19 vaccine opens for enrollment at UTHealth in Houston
University of Texas Health Science Center at Houston

A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).

Released: 15-Apr-2021 1:15 PM EDT
For veterans, a hidden side effect of COVID: Feelings of personal growth
Yale University

The U.S. military veteran population is known to have abnormally high rates of suicide, so health officials have been concerned that the COVID-19 pandemic might elevate risk of psychiatric disorders, particularly among those suffering from post-traumatic stress and related disorders.

Newswise: 262026_web.jpg
Released: 15-Apr-2021 12:55 PM EDT
Significant spread of all coronavirus variants tracked in Houston area

In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines.

Showing results

110 of 5419